论文部分内容阅读
目的:研究艾迪注射液胸腔内灌注治疗非小细胞肺癌恶性胸水的疗效。方法:将46例非小细胞肺癌患者随机分为两组:治疗组(艾迪注射液)23例和对照组(CTX化疗)23例。治疗组胸腔内灌注艾迪注射液,对照组胸腔内灌注CTX。结果:两组疗效相仿,但治疗组无毒副作用。结论:艾迪注射液胸腔内灌注治疗非小细胞肺癌恶性胸水疗效肯定,无毒副作用。
Objective: To study the curative effect of Aidi injection in the treatment of malignant pleural effusion of non-small cell lung cancer. Methods: Forty-six patients with non-small cell lung cancer were randomly divided into two groups: 23 in the treatment group (Aidi Injection) and 23 in the control group (CTX chemotherapy). The treatment group was given intraperitoneal injection of Aidi injection and the control group was given intrapleural injection of CTX. Results: The two groups had similar efficacy, but the treatment group had no toxic and side effects. Conclusion: Aidi injection intrathoracic perfusion in the treatment of malignant pleural effusion of non-small cell lung cancer with positive effect, non-toxic side effects.